Here are the facts: IPIX has had nothing but success in all its clinical trials. Any one of the conditions targeted by the drugs would be worth many, many multiples of the current share price.
(6)
(0)
Deliver breaking news, insightful commentary, and exclusive reports. Get in touch
benzingaheadline@gmail.com.
Target readers who trust our platform to stay ahead of the curve.
